News

Strategy Inc. Expands Bitcoin Portfolio Amid Criticism

Strategy Inc. Expands Bitcoin Portfolio Amid Criticism

Strategy Inc. Acquires Additional Bitcoin Holdings

Strategy Inc. (NASDAQ: MSTR) recently made headlines by purchasing 1,229 Bitcoin (BTC) for an impressive $108.8 million, marking the latest move in its long-standing strategy of accumulating cryptocurrency. This acquisition, averaging around $88,568 per Bitcoin, has added to its already substantial portfolio.

Major Purchase Funded Through Stock Sale

The company’s sustained investment strategy resumes after a significant cash injection via the sale of Class A common stock. This strategic step follows regulatory filings revealing that the firm now holds a total of 672,497 BTC, acquired for an astounding $50.44 billion and averaging $74,997 per Bitcoin.

Despite the substantial investment and holdings, Strategy Inc. has managed to achieve a BTC yield of 23.2% year-to-date in 2025, showcasing a level of profitability amidst broader market volatility.

Peter Schiff Critiques Strategy's Performance

Not everyone is convinced about Strategy's approach. Notably, investor and economist Peter Schiff has publicly criticized the company's five-year Bitcoin accumulation strategy. He points out that with an average acquisition cost nearing $75,000, Strategy's 'paper profit' of 16% translates to a sobering annual return of just over 3%.

Schiff went as far as to say that diversifying into virtually any other asset class would have been more beneficial than continuing to invest aggressively in Bitcoin.

Concerns Over Preferred Stock Strategy

Schiff has also raised alarms about the company’s preferred stock offerings, labeling them as potential traps for unsuspecting investors. He emphasizes that dividends are not guaranteed unless explicitly declared by the company, hinting that many potential investors might be unaware of this critical aspect.

Moreover, Schiff warns that if preferred stock dividends are left undeclared, they essentially disappear, leaving investors with little recourse.

Market Valuation and Investor Anxiety

Despite its vast Bitcoin holdings, Strategy’s market capitalization stands significantly lower at around $45 billion. This is in stark contrast to the fair market value of its Bitcoin assets, estimated between $59-60 billion. This discrepancy raises crucial questions about investor sentiment, particularly in light of concerns about leverage, dilution, and recent fluctuations in Bitcoin's value.

Since October 10, MSTR shares have plummeted by 50%, underperforming even Bitcoin itself, which highlights the struggles faced by the company in maintaining investor confidence.

Analyzing MSTR's Market Activity

Visual representations of MSTR's market activity reveal a sharp decline, with share prices dropping from nearly $500 in July to current levels—a staggering 68% loss. The Supertrend indicator has shifted to bearish territory at $187.86, presenting a resistance challenge for the stock, while the SAR indicator further confirms the ongoing downtrend.

Notably, MSTR has been unable to generate any meaningful price rebounds, indicating a real lack of buyer interest in its shares. All exponential moving averages currently point downward, emphasizing a persistent downward trajectory with only recent lows around $153.70 offering any semblance of support.

In the near term, the company needs to reclaim resistance within the $180-$190 range just to suggest a potential for stabilization. However, until Bitcoin finds a solid support base, Strategy Inc. is likely to experience ongoing selling pressure as investors step back from the stock.

Frequently Asked Questions

What prompted Strategy Inc. to acquire more Bitcoin?

Strategy Inc. continues to invest in Bitcoin as part of its long-term strategy, funded through recent stock sales.

How many Bitcoins does Strategy Inc. currently hold?

The company now holds a total of 672,497 Bitcoins, acquired at an average price lower than current market rates.

What is Peter Schiff's opinion on Strategy Inc.'s investments?

Peter Schiff criticizes the company for low returns on its Bitcoin investments and suggests diversifying into other assets.

What concerns does Schiff raise about preferred stocks?

Schiff warns that dividends on preferred stocks are not guaranteed, which could lead to losses for investors.

How has the market responded to Strategy Inc.'s stock?

MSTR shares have dropped significantly, underperforming relative to Bitcoin and showing ongoing bearish trends.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Female Crash Test Dummy Design to Enhance Safety

Updated Category News Views 190

National Safety Council Embraces New Crash Test Dummy Design The National Safety Council is excited about the recent efforts by the U.S. Department of Transportation to introduce a new crash test dummy design tailored specifically for women. This initiative is a significant stride in addressing the troubling trend of higher injury and fatality rates experienced by women...

Continue Reading
Empowering Women: Hines Health Services Champions Equality

Updated Category News Views 166

Empowering Women in Healthcare at Hines Health Services On International Women's Day, Hines Health Services (HHS) proudly recognizes and honors the invaluable contributions of women in the workforce, particularly within the healthcare sector. This female-led organization, where women comprise 75% of the workforce, is dedicated to fostering a culture rooted in diversity,...

Continue Reading
James Hardie Industries Faces Securities Investigation; What You Need to Know

Updated Category News Views 122

Understanding the Investigation of James Hardie Industries James Hardie Industries plc, noted for its specialized construction materials, is currently facing scrutiny regarding its business practices, particularly in relation to its sales reporting. This investigation raises critical questions for current and prospective investors about the integrity of the company's...

Continue Reading
Chapters Health System Revamps National Grief Support Initiatives

Updated Category News Views 49

Transforming Grief Support for Children Chapters Health System has taken significant steps in rebranding its grief support camps for children under a unified name and logo: Camp Brave Heart. This initiative is set to launch in 2026, reflecting the organization's dedication to providing a nurturing and supportive environment for children experiencing the loss of a loved...

Continue Reading
Enhancing Trial Participation: ProofPilot and Inspire Join Forces

Updated Category News Views 121

Enhancing Trial Participation with Innovative Partnerships In a remarkable collaboration, ProofPilot, a pioneer in Clinical Experience Platforms (CXP), has teamed up with Inspire, an esteemed online health community dedicated to patient engagement. This partnership is set to revolutionize the way patients connect with clinical trials, ultimately enhancing recruitment...

Continue Reading